Month: December 2025

MINNEAPOLIS, Dec. 19, 2025 (GLOBE NEWSWIRE) — Xcel Energy Inc. (NASDAQ: XEL) (Xcel Energy) announced today the pricing terms of its previously announced three separate offers (each an Offer and, together, the Offers) to purchase for cash up to $345,000,000 aggregate principal amount of three series of first mortgage bonds (the Bonds) issued by Northern States Power Company, a Minnesota corporation and a wholly owned subsidiary of Xcel Energy. The Offers are made upon the terms and subject to the conditions set forth in the Offer to Purchase dated December 15, 2025 relating to the Bonds (the Offer to Purchase) and the accompanying notice of guaranteed delivery (the Notice of Guaranteed Delivery and, together with the Offer to Purchase, the Tender Offer Documents). Capitalized terms used but not defined in this announcement have...

Press Release Evolution of PROACTIS SA Governance PARIS, France – (19 December 2025) — Under the terms of the Board of Directors of the company PROACTIS SA (ISIN code: FR0004052561) held on the 18th of December 2025, Mrs. Charlotte CARTER has been appointed as Director in replacement of Mrs. Bonnie MITCHELL, resigning. Charlotte Carter joined Proactis in 2013. She is Vice President for Product at Proactis, where she leads a high-performing team dedicated to investing in our next generation of software products. She brings over 12 years of experience in the Source-to-Pay software domain, with expertise in procurement, spend control and SaaS and is supported by CIPS certification and executive education from MIT Sloan. During this same meeting, Mr. Peter SHEPHERD has been appointed as Director in replacement of Mr. Graham DAVIS, resigning. Peter...

Aspo Plc  ANNOUNCEMENT  19.12.2025          Aspo Plc: Share repurchase 19.12.2025       In the Helsinki Stock Exchange         Trade date           19.12.2025  Bourse trade         Buy  Share                  ASPO  Amount             3 000 SharesAverage price/ share    6,5067 EURTotal cost            19 520,10 EUR          Aspo Plc now holds a total of 97 000 shares  including the shares repurchased on 19.12.2025       The share buybacks are executed in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5and the Commission Delegated Regulation (EU) 2016/1052.          On behalf of Aspo Plc         Nordea Bank Oyj              Sami Huttunen Ilari Isomäki       For more information, please contact:  Erkka...

Foshan, China, Dec. 19, 2025 (GLOBE NEWSWIRE) — As the festive lights go up and the year draws to a close, the familiar holiday rush begins. We spend hours scrolling through gift guides, searching for the perfect present that says, “I care about you.” We often gravitate toward the usual suspects: the latest gaming console, designer clothes, or high-end kitchen gadgets that might only see use once a year. But this Christmas and New Year, there is a shift in what families value most. After another year of navigating health challenges and environmental concerns, the most meaningful gift you can offer isn’t a toy or a trinket—it is the gift of long-term health and safety. This holiday season, VIOMI is inviting you to rethink your gift list. By upgrading your home with a cutting-edge AI water purifier, you aren’t...

Press release Montrouge, December 19 2025 REDUCTION OF RESOURCES TO THE LIQUIDITY CONTRACT WITH KEPLER CHEUVREUX In accordance with the agreement signed as of 25 October 2006, updated on 18 January 2019, and amended by Amendment No. 1 dated 6 July 2020 and by Amendment No. 2 dated 18 March 2022, Crédit Agricole S.A. (ISIN: FR0000045072) entrusted Kepler Cheuvreux with the implementation of a liquidity contract (the “Contract”). This Contract, with an initial amount of €50 million, is intended to create an active market for the shares of Crédit Agricole S.A. on the regulated market of Euronext Paris. In order to readjust the amount made available for this contract, a redemption of €1,5 million was made to the Liquidity account on December 19, 2025 (the “Redemption”). The Redemption was carried out in accordance with...

December 19, 2025 MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Articles L. 233-8 II of the Commercial Code and 223-16 of the General Regulation of the AMFDate   Shares   Voting rightsTheoretical* Exercisable**30 November 2025 43,203,225 48,976,321 48,922,224*This number is calculated on the basis of all the shares to which voting rights are attached, including shares which voting rights have been suspended, in accordance with Article 223-11 of the AMF general regulation related to the calculation of the crossing of thresholds with regard to the number of voting rights. **For information purposes, this number excludes the shares which voting rights have been suspended. The information is also available in the « Regulated Information » section of the Ipsos website: https://www.ipsos.com/en/regulated-informations/en....

BOSTON, Dec. 19, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announces that its Executive Chairman and Founder, Mr. Gabriele Cerrone, has purchased 97,687 common shares, bringing his total holding to 43,374,830 common shares, which is 36.08% of issued share capital. About Foralumab Foralumab, a fully human anti-CD3 monoclonal antibody, is a biological drug candidate that has been shown to stimulate T regulatory cells when dosed intranasally. At present, 14 patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) have been dosed in an open-label intermediate sized Expanded Access...

HOUSTON, Dec. 19, 2025 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (“Salarius” or the “Company”) today announced that its 2025 Annual Meeting of Stockholders (the “Annual Meeting”) scheduled for and convened on December 19, 2025 has been adjourned for the purpose of soliciting additional votes with respect to the proposals described in the Company’s definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission (the “SEC”) on November 7, 2025. The required quorum for the transaction of business at the Annual Meeting is 34% of the outstanding shares entitled to vote. There was less than the required voting power represented in person or by proxy at the meeting. The Annual Meeting will be reconvened on December 31, 2025 at 10.00 a.m. Central Time and will continue to be held...